Live
- Grain procurement should be expedited - Additional Collector K Sitarama Rao
- Custodial death: Madras HC directs Villupuram Collector to exhume body
- PGA Championship: Schauffele leads as Scheffler overcomes trip to Police Station with 66; Theegala is third
- Golf: Pranavi, Diksha among three Indians to make the cut in German Masters
- Fight is between ‘Ram Bhakt’ and ‘Ram Drohi’, ‘Rashtra Bhakt’ and ‘Rashtra Drohi’: Yogi Adityanath
- District Election Officer Calls for Armed Arrangements for Legislative Council Graduate By-Election
- Xavi publicly announces he will stay at Barca despite rumours of President Laporta being unhappy
- A huge fire broke out in an electronic shop in the district center
- Humans not at risk of deadly chronic wasting disease: Study
- IPL 2024: As a batter, I know I didn't live up to the standard, says Rohit Sharma
Decision on foreign vaccines in 3 days
New Delhi: India's drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced vaccines...
New Delhi: India's drug regulator will take a decision on applications seeking approval for restricted emergency use of foreign produced vaccines within three working days from the date of submission, the government said on Thursday.
The Central Drug Authority, CDSCO, will process applications for registration certificates (registration of overseas manufacturing site and product; in this case Covid vaccine) and import license within three working days from the date of approval of restricted use in emergency situation.
The CDSCO issued detailed guidelines specifying regulatory pathway for approval of foreign approved Covid-19 vaccines after the central government on Tuesday decided to fast-track emergency approvals for all coronavirus jabs that have been given a similar nod by the WHO or regulators in the United States, Europe, Britain or Japan.
The Union Health Ministry on Thursday issued regulatory pathways for foreign produced Covid-19 vaccines according to which the CDSCO has prepared detailed guidelines specifying regulatory pathway for approval of foreign approved Covid-19 vaccines.
The government had on April 13 approved streamlining and fast tracking of regulatory system for Covid-19 vaccines approved for restricted use by the US FDA, EMA, UK MHRA, PMDA Japan or which are listed in WHO Emergency Use Listing (EUL).
